| scholarly article | Q13442814 |
| P356 | DOI | 10.1200/JCO.2001.19.1.171 |
| P8608 | Fatcat ID | release_lf76v3uedfe7xpsian3ni4auei |
| P698 | PubMed publication ID | 11134210 |
| P2093 | author name string | B N Rao | |
| J Harper | |||
| C B Pratt | |||
| W H Meyer | |||
| J J Jenkins | |||
| A S Pappo | |||
| B D Fletcher | |||
| N M Marina | |||
| D M Parham | |||
| C A Poquette | |||
| M Neel | |||
| H H Mahmoud | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 171-182 | |
| P577 | publication date | 2001-01-01 | |
| P1433 | published in | Journal of Clinical Oncology | Q400292 |
| P1476 | title | Carboplatin/ifosfamide window therapy for osteosarcoma: results of the St Jude Children's Research Hospital OS-91 trial | |
| P478 | volume | 19 |
| Q34545093 | Adjuvant therapy of osteosarcoma--A Phase II trial: Southwest Oncology Group study 9139. |
| Q84953121 | Antineoplastic drug, carboplatin, protects mice against visceral leishmaniasis |
| Q80510573 | Biology and therapy of malignant solid tumors in childhood |
| Q37152000 | Bone tumors in adolescents and young adults |
| Q39429404 | Carboplatin and Doxorubicin in Treatment of Pediatric Osteosarcoma: A 9-year Single Institute Experience in the Northern Region of Thailand |
| Q44614940 | Carboplatin-Induced Oxidative Injury in Rat Inferior Colliculus |
| Q43718439 | Carboplatin-induced oxidative stress in rat cochlea |
| Q90222934 | Curative-intent radiotherapy for pediatric osteosarcoma: The St. Jude experience |
| Q41444080 | Determination of Methotrexate, 7-Hydroxymethotrexate, and 2,4-Diamino-N10-methylpteroic Acid by LC-MS/MS in Plasma and Cerebrospinal Fluid and Application in a Pharmacokinetic Analysis of High-Dose Methotrexate |
| Q37563763 | Does ifosfamide therapy improve survival of patients with dedifferentiated chondrosarcoma? |
| Q44208465 | Dose response of carboplatin-induced nephrotoxicity in rats |
| Q47655246 | Electrophysiological findings in the Sprague-Dawley rat induced by moderate-dose carboplatin |
| Q36429326 | Estimation of potential excess cancer incidence in pediatric 201Tl imaging |
| Q36946864 | Feasibility and dose discovery analysis of zoledronic acid with concurrent chemotherapy in the treatment of newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group |
| Q36503647 | Frontline treatment of localized osteosarcoma without methotrexate: results of the St. Jude Children's Research Hospital OS99 trial |
| Q44837129 | High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma |
| Q38219831 | Historical perspective on the introduction and use of chemotherapy for the treatment of osteosarcoma |
| Q36623745 | Increased pre-therapeutic serum vascular endothelial growth factor in patients with early clinical relapse of osteosarcoma |
| Q35587577 | Influence of bony resection margins and surgicopathological factors on outcomes in limb-sparing surgery for extremity osteosarcoma |
| Q44807634 | Influence of mesna on the pharmacokinetics of cisplatin and carboplatin in pediatric cancer patients |
| Q35146153 | Limb salvage in musculoskeletal oncology |
| Q45967061 | Long-term results of the Spanish Protocol SO-95 for the treatment of non-metastatic high-grade osteosarcoma of the extremities in children. |
| Q34976539 | Management of local recurrence of pediatric osteosarcoma following limb-sparing surgery |
| Q46850363 | Metastatic osteosarcoma |
| Q80002104 | Outcome after local recurrence of osteosarcoma: the St. Jude Children's Research Hospital experience (1970-2000) |
| Q36694532 | Outcome of flat bone sarcomas (other than Ewing's) in children and adolescents: a study of 25 cases |
| Q37656795 | Pathologic fracture in childhood and adolescent osteosarcoma: A single-institution experience |
| Q36515558 | Patients with osteosarcoma with a single pulmonary nodule on computed tomography: a single-institution experience |
| Q83206611 | Predictors of outcome in dogs treated with adjuvant carboplatin for appendicular osteosarcoma: 65 cases (1996–2006) |
| Q38689748 | Prognosticating metastatic osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate and delayed metastasectomy: a single center experience of 102 patients |
| Q35677274 | Recurrent osteosarcoma with a single pulmonary metastasis: a multi-institutional review. |
| Q34754346 | Survival of pediatric patients after relapsed osteosarcoma: the St. Jude Children's Research Hospital experience. |
| Q36514299 | The Current and Future Therapies for Human Osteosarcoma |
| Q33367102 | The feasibility of neoadjuvant high-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with nonmetastatic high grade localized osteosarcoma: results of a phase II study |
| Q79864580 | Upfront window trial of topotecan in previously untreated children and adolescents with poor prognosis metastatic osteosarcoma: children's Cancer Group (CCG) 7943 |
| Q36356334 | ZD6474, a new treatment strategy for human osteosarcoma, and its potential synergistic effect with celecoxib |
Search more.